SYS-CON MEDIA Authors: Vormetric Blog, Jason Bloomberg, Liz McMillan, Pat Romanski, Elizabeth White

News Feed Item

Michelson Diagnostics Announces £1.98 Million Financing

ORPINGTON, England, January 13, 2014 /PRNewswire/ --

Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography ('OCT') technology, is delighted to announce the first closing of its Series A2 Financing. The round, which was oversubscribed, raised £1.98 million ($3.25million) from existing investors, led by Octopus Investments and supported by Catapult Venture Managers Ltd and London Business Angels, and several business angels.

The funds will be used for several purposes including expanding VivoSightTM sales in Germany, where the system was launched in mid-2011 and where it is reimbursed for use in the diagnosis of non-melanoma skin cancer (NMSC), the commonest skin malignancy.  The Company will also invest further in the development of a compact, more portable second generation VivoSight System with an anticipated lower cost of manufacture and enhanced functionality. Part of the monies raised will be used to initiate US market access with a pilot clinical study planned. The Company believes that the US is the largest single market for the VivoSight system.

VivoSight is a medical imaging system, which uses Michelson Diagnostics world-leading, patented, multi-beam OCT technology to non-invasively view all the layers of the skin in great detail for the first time.   VivoSight provides clinicians with real-time, high definition images of the skin through a fast, accurate and reliable imaging system.  The Company's initial focus is in the diagnosis of non-melanoma skin cancer ('NMSC'), which is the most common skin cancer with approximately 3.5 million new cases in the USA each year.[1]

VivoSight currently has regulatory clearance in Europe and Australia, and FDA 510(k) clearance in the US.  Following the successful launch, use of VivoSight in Germany has grown rapidly, with more than 2,500 scan procedures performed by December 2013 at ten clinics. The Company is now entering the Australian and Swiss markets.  

In addition, Michelson Diagnostics is the only Company generating Level 1 Clinical Evidence of the value of OCT in the diagnosis of NMSC.  Interim data from the Company's prospective multi-centre study is very promising.  Positive results from the trial are expected to accelerate the adoption of VivoSight as a diagnostic tool and to aid the Company in achieving reimbursement in the US and elsewhere. The trial is expected to complete in the first quarter of 2014 and full results will be presented at the annual meeting of the American Academy of Dermatology, 21-24 March 2014, in Denver, Colorado.

Jon Holmes, Chief Executive Officer of Michelson Diagnostics, commented "I would like to thank our investors for their continued support; the completion of this financing concludes a year in which we have made real progress, especially in our market access in Germany.  We now look forward to a very promising 2014 which will include the publication of Level 1 Clinical Evidence in the diagnosis of NMSC."

Simon Andrews, a member of the Ventures team at Octopus Investments, said: "The team at Michelson Diagnostics has really impressed us over the past eighteen months. The market for non-invasive therapy is developing and we are very pleased to see the promising early results of the multi-centre study which should accelerate the adoption of VivoSight. The business has made excellent progress to date and we are excited about the next stage of its growth and development."

--------------------------------------------------

1. M. A. Rogers Hw Fau - Weinstock, A. R. Weinstock Ma Fau - Harris, M. R. Harris Ar Fau - Hinckley, S. R. Hinckley Mr Fau - Feldman, A. B. Feldman Sr Fau - Fleischer, B. M. Fleischer Ab Fau - Coldiron, et al., "Incidence estimate of nonmelanoma skin cancer in the United States, 2006," 20100316 DCOM- 20100413.

Michelson Diagnostics was advised by Catalysis Capital Partners Limited and Edwards Wildman Palmer UK LLP and Octopus Investment were advised by Shoosmiths LLP.

For further information
Michelson Diagnostics    
Jon Holmes, Chief Executive Officer  
Tel: +44-(0)20-8308-1695

FTI Consulting  
Simon Conway / Mo Noonan / Victoria Foster Mitchell   
Tel: +44-(0)20-7831-3113

FieldHouse Associates (for Octopus Investments)                       
Cordelia Meacher
Tel: +44-(0)7961-311080

Notes to editors

About Michelson Diagnostics and the VivoSight System

Michelson Diagnostics has developed a world-leading medical imaging technology, known as multi-beam Optical Coherence Tomography ('OCT'), that uses an advanced laser scanner to 'see' into tissue with unprecedented image resolution and quality of image. Multi-beam OCT has many potential clinical applications, but we are currently focusing on dermatology.

Our vision is for our VivoSight OCT system to become the standard of care for the non-invasive diagnosis and monitoring of certain diseases and conditions that affect cutaneous and epithelial linings of the body. We currently generate revenues from our first commercial application of VivoSight which is in the diagnosis of non-melanoma skin cancer (NMSC).

VivoSight has regulatory clearance in Europe, USA and Australia, for use by trained clinicians in their assessment of the patient's medical condition.  We have launched VivoSight in Germany where the VivoSight scan is reimbursed for patients with private healthcare insurance.

The Company, based in Orpington, Kent, was founded in 2006 and has 18 employees. It has sales offices in Germany and USA. It has been supported through funding from a syndicate of Venture Capital, corporate and private investors including Octopus, Catapult Ventures and Angel Investors.  

For more information about Michelson Diagnostics, see http://www.michelsondiagnostics.com.

About Octopus Investments

Founded in 2000, Octopus is one of the UK's fastest growing investment management companies. We currently manage £3 billion of assets on behalf of 50,000 customers. We offer a straight-talking approach to investments, exceptional customer service and a range of products that do what they say they will.

The Ventures team at Octopus

The Ventures team at Octopus are straight talking human investors that back talented people rather than specific sectors. We focus on identifying fast growth businesses which can scale explosively to create, transform or dominate an industry. We can invest from £250,000 to £5 million and prefer to partner teams based in the UK.

The work of our Ventures team is supported by access to the Octopus Venture Partners, a network of approximately 100 outstanding business leaders, entrepreneurs and private investors providing an invaluable wealth of expertise and resource for our portfolio companies, as well as investing on a deal-by-deal basis alongside Octopus venture funds. This blend of knowledge and skill has allowed us to help many great companies across several sectors thrive in recent years, including: Zoopla; graze.com; SwiftKey; and Secret Escapes.

For more information visit http://www.octopusinvestments.com.

About Catapult Venture Managers Ltd

Catapult Venture Managers Ltd is a leading private equity fund manager with one of the largest investment teams in the Midlands operating from offices in Birmingham and Leicester. With £80m in funds under its management Catapult seek equity investment opportunities from £200k to £2m in growing businesses.

Contact details for Catapult
e:  [email protected]
t: +44-(0)121-616-0180 (Birmingham) or +44-(0)116-238-8200 (Leicester)

About London Business Angels

London Business Angels is one of the oldest, most respected and successful Business Angel Investment Networks in the UK and indeed Europe. Since 1982 we have been connecting high growth small and medium sized enterprises with investment through our network of experienced and discerning business angel investors.

Our highly experienced management team are established leaders in the development of new angel-led early stage investment initiatives, and are able to leverage nearly 30 years investment experience. The team are supported by a board of leading international players from finance, Angel Investment, Venture Capital and Business.

London Business Angels is a founding member of the UK Business Angels Association, the industry's best practice trade association. LBA is also a member of EBAN, the European Business Angels Network.

London Business Angels is part of the Angel Capital Group, focusing on providing both investment and knowledge to high growth businesses.

Contact details for London Business Angels
e:  [email protected]
t: +44-(0)20-7321-5672

SOURCE Michelson Diagnostics

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
The industrial software market has treated data with the mentality of “collect everything now, worry about how to use it later.” We now find ourselves buried in data, with the pervasive connectivity of the (Industrial) Internet of Things only piling on more numbers. There’s too much data and not enough information. In his session at @ThingsExpo, Bob Gates, Global Marketing Director, GE’s Intelligent Platforms business, to discuss how realizing the power of IoT, software developers are now focu...
“This win means a great deal to us because it is decided by the readers – the people who understand how use of our technology enables new insights that drive the business,” said Matt Davies, senior director, EMEA marketing, Splunk. “Splunk Enterprise enables organizations to improve service levels, reduce operations costs, mitigate security risks, enhance DevOps collaboration, create new product and service offerings and obtain deeper insight into customer behavior. Being named Best Business App...
Things are being built upon cloud foundations to transform organizations. This CEO Power Panel at 15th Cloud Expo, moderated by Roger Strukhoff, Cloud Expo and @ThingsExpo conference chair, addressed the big issues involving these technologies and, more important, the results they will achieve. Rodney Rogers, chairman and CEO of Virtustream; Brendan O'Brien, co-founder of Aria Systems, Bart Copeland, president and CEO of ActiveState Software; Jim Cowie, chief scientist at Dyn; Dave Wagstaff, VP ...
“DevOps is really about the business. The business is under pressure today, competitively in the marketplace to respond to the expectations of the customer. The business is driving IT and the problem is that IT isn't responding fast enough," explained Mark Levy, Senior Product Marketing Manager at Serena Software, in this SYS-CON.tv interview at DevOps Summit, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
Today’s enterprise is being driven by disruptive competitive and human capital requirements to provide enterprise application access through not only desktops, but also mobile devices. To retrofit existing programs across all these devices using traditional programming methods is very costly and time consuming – often prohibitively so. In his session at @ThingsExpo, Jesse Shiah, CEO, President, and Co-Founder of AgilePoint Inc., discussed how you can create applications that run on all mobile ...
At 15th Cloud Expo, Shrikant Pattathil, Executive Vice President at Harbinger Systems, demos a video delivery platform that helps you do interactive videos. He discusses how Harbinger is accomplishing it in the cloud world, the problems they faced and the choices they made to get around these problems.
The Internet of Things is tied together with a thin strand that is known as time. Coincidentally, at the core of nearly all data analytics is a timestamp. When working with time series data there are a few core principles that everyone should consider, especially across datasets where time is the common boundary. In his session at Internet of @ThingsExpo, Jim Scott, Director of Enterprise Strategy & Architecture at MapR Technologies, discussed single-value, geo-spatial, and log time series dat...
15th Cloud Expo, which took place Nov. 4-6, 2014, at the Santa Clara Convention Center in Santa Clara, CA, expanded the conference content of @ThingsExpo, Big Data Expo, and DevOps Summit to include two developer events. IBM held a Bluemix Developer Playground on November 5 and ElasticBox held a Hackathon on November 6. Both events took place on the expo floor. The Bluemix Developer Playground, for developers of all levels, highlighted the ease of use of Bluemix, its services and functionalit...
In her General Session at 15th Cloud Expo, Anne Plese, Senior Consultant, Cloud Product Marketing, at Verizon Enterprise, focused on finding the right mix of renting vs. buying Oracle capacity to scale to meet business demands, and offer validated Oracle database TCO models for Oracle development and testing environments. Anne Plese is a marketing and technology enthusiast/realist with over 19+ years in high tech. At Verizon Enterprise, she focuses on driving growth for the Verizon Cloud platfo...
Cultural, regulatory, environmental, political and economic (CREPE) conditions over the past decade are creating cross-industry solution spaces that require processes and technologies from both the Internet of Things (IoT), and Data Management and Analytics (DMA). These solution spaces are evolving into Sensor Analytics Ecosystems (SAE) that represent significant new opportunities for organizations of all types. Public Utilities throughout the world, providing electricity, natural gas and water,...
The 3rd International Internet of @ThingsExpo, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that its Call for Papers is now open. The Internet of Things (IoT) is the biggest idea since the creation of the Worldwide Web more than 20 years ago.
SYS-CON Media announced that Splunk, a provider of the leading software platform for real-time Operational Intelligence, has launched an ad campaign on Big Data Journal. Splunk software and cloud services enable organizations to search, monitor, analyze and visualize machine-generated big data coming from websites, applications, servers, networks, sensors and mobile devices. The ads focus on delivering ROI - how improved uptime delivered $6M in annual ROI, improving customer operations by minin...
Between the compelling mockups and specs produced by your analysts and designers, and the resulting application built by your developers, there is a gulf where projects fail, costs spiral out of control, and applications fall short of requirements. In his session at DevOps Summit, Charles Kendrick, CTO and Chief Architect at Isomorphic Software, will present a new approach where business and development users collaborate – each using tools appropriate to their goals and expertise – to build mo...
There is no doubt that Big Data is here and getting bigger every day. Building a Big Data infrastructure today is no easy task. There are an enormous number of choices for database engines and technologies. To make things even more challenging, requirements are getting more sophisticated, and the standard paradigm of supporting historical analytics queries is often just one facet of what is needed. As Big Data growth continues, organizations are demanding real-time access to data, allowing immed...
The true value of the Internet of Things (IoT) lies not just in the data, but through the services that protect the data, perform the analysis and present findings in a usable way. With many IoT elements rooted in traditional IT components, Big Data and IoT isn’t just a play for enterprise. In fact, the IoT presents SMBs with the prospect of launching entirely new activities and exploring innovative areas. CompTIA research identifies several areas where IoT is expected to have the greatest impac...